The estimated Net Worth of Richard B. Lanman is at least $9.5 Milhão dollars as of 1 November 2019. Dr Lanman owns over 5,764 units of Guardant Health Inc stock worth over $2,183,064 and over the last 7 years he sold GH stock worth over $6,773,844. In addition, he makes $540,146 as Advisor at Guardant Health Inc.
Dr has made over 5 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 5,764 units of GH stock worth $40,060 on 1 November 2019.
The largest trade he's ever made was exercising 136,244 units of Guardant Health Inc stock on 15 April 2019 worth over $294,287. On average, Dr trades about 16,201 units every 15 days since 2017. As of 1 November 2019 he still owns at least 87,779 units of Guardant Health Inc stock.
You can see the complete history of Dr Lanman stock trades at the bottom of the page.
Dr. Richard B. Lanman is the Advisor at Guardant Health Inc.
As the Advisor of Guardant Health Inc, the total compensation of Dr Lanman at Guardant Health Inc is $540,146. There are 6 executives at Guardant Health Inc getting paid more, with Michael Wiley having the highest compensation of $2,216,070.
Dr Lanman is 65, he's been the Advisor of Guardant Health Inc since . There are 3 older and 12 younger executives at Guardant Health Inc. The oldest executive at Guardant Health Inc is Stanley Meresman, 73, who is the Independent Director.
Richard's mailing address filed with the SEC is 27042 TOWNE CENTRE DR., SUITE 270, FOOTHILL RANCH, CA, 92610.
Over the last 6 years, insiders at Guardant Health Inc have traded over $2,653,630,540 worth of Guardant Health Inc stock and bought 2,438,210 units worth $45,173,576 . The most active insiders traders include Bluebird (Cayman) Ltd Softb..., Bluebird (Cayman) Ltd Svf E..., eHelmy Eltoukhy. On average, Guardant Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of $2,415,822. The most recent stock trade was executed by Kumud Kalia on 9 September 2024, trading 6,545 units of GH stock currently worth $162,774.
we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.
Guardant Health Inc executives and other stock owners filed with the SEC include: